G935-1813 Screening compound: 1-(2,3-dihydro-1H-indol-1-yl)-2-(3,5-dimethyl-4-{[4-(4-methylpiperazine-1-carbonyl)piperidin-1-yl]sulfonyl}-1H-pyrazol-1-yl)ethan-1-one

G935-1813 Screening compound: 1-(2,3-dihydro-1H-indol-1-yl)-2-(3,5-dimethyl-4-{[4-(4-methylpiperazine-1-carbonyl)piperidin-1-yl]sulfonyl}-1H-pyrazol-1-yl)ethan-1-one
G935-1813 Screening compound: 1-(2,3-dihydro-1H-indol-1-yl)-2-(3,5-dimethyl-4-{[4-(4-methylpiperazine-1-carbonyl)piperidin-1-yl]sulfonyl}-1H-pyrazol-1-yl)ethan-1-one alternative view

Chemical Structure Depiction of ChemDiv screening compound G935-1813
1-(2,3-dihydro-1H-indol-1-yl)-2-(3,5-dimethyl-4-{[4-(4-methylpiperazine-1-carbonyl)piperidin-1-yl]sulfonyl}-1H-pyrazol-1-yl)ethan-1-one

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

G935-1813

Molecular Formula

C26H36N6O4S (C26 H36 N6 O4 S)

Compound Name

1-(2,3-dihydro-1H-indol-1-yl)-2-(3,5-dimethyl-4-{[4-(4-methylpiperazine-1-carbonyl)piperidin-1-yl]sulfonyl}-1H-pyrazol-1-yl)ethan-1-one

IUPAC name

1-(23-dihydro-1H-indol-1-yl)-2-(35-dimethyl-4-{[4-(4-methylpiperazine-1-carbonyl)piperidin-1-yl]sulfonyl}-1H-pyrazol-1-yl)ethan-1-one

SMILES

Cc(n(CC(N(CC1)c2c1cccc2)=O)nc1C)c1S(N(CC1)CCC1C(N1CCN(C)CC1)=O)(=O)=O

InChI

InChI=1S/C26H36N6O4S/c1-19-25(20(2)32(27-19)18-24(33)31-13-10-21-6-4-5-7-23(21)31)37(35,36)30-11-8-22(9-12-30)26(34)29-16-14-28(3)15-17-29/h4-7,22H,8-18H2,1-3H3

InChI Key

DBWFGVXETBERGR-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD15075967

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

528.68

Hydrogen Bond Acceptors Count

11.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

10

Partition Coefficient, logP

0.350

Distribution Coefficient, logD

0.002

Water Solubility, LogSw

-2.09

Polar Surface Area

81.779

Acid Dissociation Constant (pKa)

23.38

Base Dissociation Constant (pKb)

7.49

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

57.70

G935-1813 in Drug Discovery

Included in Screening Libraries

GPCR Targeted Library (31838 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with G935-1813 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound G935-1813?
Check Price and Availability of G935-1813, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of G935-1813 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for G935-1813
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for G935-1813
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of G935-1813 available by request